Drugs Flashcards
Propofol (diprovan) use and MOA
anti-microbial and anti-emetic properties
hypnotic
dissociates GABA from receptor
Propofol (diprovan) - metabolism, elimination
liver, kidney
Propofol (diprovan) considerations
venous dilation, bronchodilation,
decrease BP (preload, afterload, contractility)
respiratory depression, neuroprotective (decreases CBF, ICP)
lidocaine 2% use/dose
propofol causes pain peripherally
0.5-1 mg/kg IV prior to propofol administration
Propofol (diprovan) - dose
1-2.5 mg/kg IV - induction
100-200 mcg/kg/min - TIVA
25-75 mcg/kg/min - conscious sedation
10 mcg/kg/min - antiemetic
2-4 min half-life
PRIS (propofol infusion syndrome)
usually from long term, high dose therapy: hypotension, dysrhythmias, rhabdo, ARF, hepatomegaly, metabolic acidosis, hyperkalemia, lipedemia
barbiturates - MOA
bind to GABAa receptors, depress RAS, suppress acetylcholine transmission
barbiturates
anticonvulsant, decreased vasc resistance, muscle excitation, myocardial and respiratory depression, decreased CRMO2, sedation, hypnosis
barbiturates contraindication
porphyria, heme synthesis metabolic error::: Severe abdominal pain, N/V, ANS instability, electrolyte disturbances, muscle weakness, neuropsychiatric changes including seizures, cardiac instability
thiopenthal
usually 500mg vial, dilute with 20 ml sterile water - 25mg/ml
adult dosing 3-5mg/kg
peak at 1 min, 5-8 min duration of action
methohexitol (brevitol)
1-2 mg/kg IV
ultra-short acting barbiturate
etomidate (amidate)
20mg/10ml = 2 mg/ml GABA mimetic Known for its CV stability!! Reduces CBF, ICP, CMR02 anticonvulsant ADRENAL SUPRESSION 0.2-0.4 mg/kg
benzodiazepines - effect
Anxiolysis Amnesia Sedation Muscle relaxation Hypnosis Anticonvulsant
benzodiazepines - commonly used
Midazolam (Versed) Half-life (1.7-2.6 hrs) Lorazepam (Ativan) Half-life (10-22 hrs) Diazepam (Valium) Half-life (36-50 hrs)
Flumazenil (Romazicon)
Benzodiazepine antagonist
Initial dose: 0.2 mg IV ; repeat doses at 0.1 mg IV (max total 1 mg IV)
Duration of action 30-60 minutes
Continuous infusion: 0.1 – 0.4 mg/hr IV